Resideo Technologies Pops As Honeywell Indemnity Buyout Boosts Growth Story

Resideo Technologies (REZI) has removed a significant structural overhang by buying out its long-standing Honeywell indemnification for $1.59 billion, a move expected to add approximately $0.40 to annual non-GAAP EPS and clear the path for cleaner earnings and the planned ADI Global spin-off in 2H26. This transformational action prompted Morgan Stanley to upgrade REZI to Overweight, raising its price target from $24 to $35, with analyst Erik Woodring forecasting a 2026 non-GAAP EPS of $3.02, significantly above consensus, as the market is seen to be underestimating the full impact of this development. REZI shares surged over 14% on the news.

Analysis

Resideo Technologies (REZI) has executed a transformational strategic action by terminating its long-standing indemnification agreement with Honeywell for a one-time payment of $1.59 billion, funded by approximately $400 million in cash and $1.2 billion in new debt. This move eliminates a significant structural overhang that previously required $140 million in annual cash payments and deterred comprehensive investor diligence. The transaction is immediately accretive, projected to add an estimated 40 cents to annual non-GAAP EPS even after accounting for financing costs. This development prompted Morgan Stanley to upgrade REZI to Overweight and increase its price target to $35 from $24, citing a clearer path to future earnings. The analyst's 2026 non-GAAP EPS estimate of $3.02 stands roughly 23% above consensus, suggesting the market has not yet fully priced in the financial benefits. Furthermore, the resolution of this liability clears the way for the planned spin-off of its ADI Global distribution business in the second half of 2026, a key catalyst for unlocking sum-of-the-parts value. This strategic de-risking is supported by strong underlying operational performance, including a recent quarter that beat guidance with the strongest organic growth in 15 quarters, leading to a 14.02% surge in REZI's share price to $31.33.

Key Decisions for Investors

• Investors should re-evaluate Resideo's valuation, as the removal of the Honeywell indemnification fundamentally de-risks the company and simplifies its financial narrative.
• Consider the potential for further upside, as consensus earnings estimates may not yet fully incorporate the projected 40-cent annual EPS accretion and Morgan Stanley's 2026 EPS forecast of $3.02 is 23% above the current street view.
• Monitor progress toward the planned ADI Global spin-off in 2H26, which now has a clearer path and represents a significant catalyst for unlocking shareholder value.